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ABSTRACT 
The fast dissolving tablets of Promethazine Theoclate were prepared by sublimation technique, using 32 full factorial design. This 
research work aimed to study and to develop a unique drug delivery system for immediate release of drugs which can dissolve 
readily when placed in the oral cavity. The different subliming agents (Camphor, Urea and Menthol) in varying concentration (5-
15% w/w) were used to develop the tablets. Total 12 formulations were prepared and evaluated for pre-compression and post 
compression characteristics. The optimization of the batches was carried out using 32 full factorial design and results of polynomial 
equation were analyzed using ANOVA and regression analysis. By the use of desirability approach final optimized formulation was 
prepared.  
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INTRODUCTION: 
Despite of tremendous innovations in drug delivery, the 
oral route remains the preferred route for administration 
of therapeutic agents because of accurate dosage, low 
cost therapy, self medication, non invasive method and 
ease of administration leading to high level of patient 
compliance. Pediatric patients may suffer from ingestion 
problems as a result of underdeveloped muscular and 
nervous control. Moreover, patients traveling with little 
or no access to water, limit utility of orally administered 
conventional tablets or capsules
1, 2. 
The task of developing rapidly disintegrating tablets is 
accomplished by using a suitable diluents and 
Superdisintegrants. The Promethazine Theoclate is 
classified under anti-emetic drug category which 
undergoes extensive gastric and first pass metabolism 
via oral administration causing low bioavailability, 
thereby reducing the efficacy of controlling vomiting. 
Fast dissolving tablets of Promethazine Theoclate were 
designed for rapid and complete oral absorption for 
achieving a therapeutic success. Thus the objective of 
the work was to formulate and optimize mouth 
dissolving tablets of Promethazine Theoclate, having 
adequate mechanical strength, rapid disintegration and 
fast action. A3
2
 full factorial design is applied for the 
optimization of the fast dissolving tablets. 
MATERIALS AND METHODS: 
Promethazine Theoclate was obtained from Cipla 
(Baddi, India), Menthol was obtained from S.D. Fine 
(Mumbai, India). Camphor and urea were obtained from 
LobaChem Pvt. Ltd., (Mumbai, India). 
Preparation of Promethazine Theoclate Tablets by 
Sublimation Technique 
2, 3, 4
 
For preparation of fast dissolving tablets subliming 
agents (camphor, urea and menthol) were incorporated 
in varying concentration (5-15% w/w). All ingredients 
were co-grounded in glass pestle mortar. The mixed 
blends of excipients were compressed using a single 
punch machine to produce flat faced tablets weighing 
100 mg. Tablets were subjected for drying for 6 h under 
vacuum (30 kpa) at 50º for sublimation to make tablets 
porous. 
Evaluation 
Precompression characterization: Bulk Density, Tapped 
Density, Compressibility index, Angle of repose and 
Hausners Ratio. 
Post compression characterization 
Friability, Wetting Time, In VitroDispersion time and 
Disintegration time 
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Table 1: Formulation by varying Subliming Agents 
Ingredients F1 F2 F3 F4 F5 F6 F7 F8 F9 F10 
*
 F11 
#
 F12 
$
 
PMT 6 6 6 6 6 6 6 6 6 6 6 6 
Camphor 5 10 15       5 10 15 
Menthol    5 10 15       
Urea       5 10 15    
Crospovidone          2 2 2 
Avicel PH102 45 40 35 45 40 35 45 40 35 43 38 33 
Dextrose 20 20 20 20 20 20 20 20 20 20 20 20 
Lactose 
monohydrate 
20 20 20 20 20 20 20 20 20 20 20 20 
Talc 2 2 2 2 2 2 2 2 2 2 2 2 
Magnesium 
stearate 
2 2 2 2 2 2 2 2 2 2 2 2 
 
Preparation of Factorial Design Batches 
The raw materials were passed through a no. 100 screen 
prior to mixing. Promethazine Theoclate, Crospovidone, 
Camphor, urea, Avicel and lactose were mixed using a 
glass mortar and pestle. The blends were lubricated with 
2% w/w Talc and 2% w/w Magnesium Stearate. The 
blends ready for compression were converted into tablets 
using a single-punch tablet machine. The composition of 
the factorial design batches is shown in Table 2 
respectively. 
RESULTS AND DISCUSSION: 
The fast dissolving tablets of Promethazine Theoclate 
were successfully prepared by sublimation technology. 
Total twelve formulations were prepared and optimized 
using 3
2
 full factorial design; that after the ANOVA was 
applied and the formulations showed the significant 
model. Using the desirability approach the final 
optimized formulation was prepared with the targeted 
results. 
Table 2: Optimized Formulation (PMT) 
Formulation OPT 
Promethazine Theoclate 6 
Camphor 10.62 
Crospovidone 2.59 
Lacotse Monohydrate 20 
Avicel PH 102 36.79 
Dextrose  20 
Talc 2.00 
Magnesium Stearate 2.00 
Evaluation  
Weight (mg) 98.014±2.225  
Hardness (kg/ cm
2
) 3.8±0.135  
Friability (%) 0.480±0.028  
Disintegration time (s) 28±2.01  
Wetting time (s)  22±1.98 
Drug Content (%)  97.35±2.325 
 
 
Figure 1. Response Surface for Disintegration Time 
 
 Figure 2. Response Surface for Friability  
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CONCLUSION: 
The results of a 3
2 
full factorial design revealed that the 
amount of Camphor and Crospovidonesignificantly 
affect the dependent variables, disintegration time, 
andpercentage friability. It is thus concluded that by 
adopting a systematic formulationapproach, an optimum 
point can be reached in the shortest time with minimum 
efforts. 
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